The vitamin D receptor is present in caveolae-enriched plasma membranes and binds 1 alpha,25(OH)2-vitamin D3 in vivo and in vitro - PubMed (original) (raw)
. 2004 Nov;18(11):2660-71.
doi: 10.1210/me.2004-0116. Epub 2004 Jul 22.
Affiliations
- PMID: 15272054
- DOI: 10.1210/me.2004-0116
The vitamin D receptor is present in caveolae-enriched plasma membranes and binds 1 alpha,25(OH)2-vitamin D3 in vivo and in vitro
Johanna A Huhtakangas et al. Mol Endocrinol. 2004 Nov.
Abstract
The steroid hormone 1 alpha,25(OH)(2)-vitamin D(3) (1,25D) regulates gene transcription through a nuclear receptor [vitamin D receptor (VDR)] and initiation of rapid cellular responses through a putative plasma membrane-associated receptor (VDR(mem)). This study characterized the VDR(mem) present in a caveolae-enriched membrane fraction (CMF), a site of accumulation of signal transduction agents. Saturable and specific [(3)H]-1,25D binding in vitro was found in CMF of chick, rat, and mouse intestine; mouse lung and kidney; and human NB4 leukemia and rat ROS 17/2.8 osteoblast-like cells; in all cases the 1,25D K(D) binding dissociation constant = 1-3 nM. Our data collectively support the classical VDR being the VDR(mem) in caveolae: 1) VDR antibody immunoreactivity was detected in CMF of all tissues tested; 2) competitive binding of [(3)H]-1,25D by eight analogs of 1,25D was significantly correlated between nuclei and CMF (r(2) = 0.95) but not between vitamin D binding protein (has a different ligand binding specificity) and CMF; 3) confocal immunofluorescence microscopy of ROS 17/2.8 cells showed VDR in close association with the caveolae marker protein, caveolin-1, in the plasma membrane region; 4) in vivo 1,25D pretreatment reduced in vitro [(3)H]-1,25D binding by 30% in chick and rat intestinal CMF demonstrating in vivo occupancy of the CMF receptor by 1,25D; and 5) comparison of [(3)H]-1,25D binding in VDR KO and WT mouse kidney tissue showed 85% reduction in VDR KO CMF and 95% reduction in VDR KO nuclear fraction. This study supports the presence of VDR as the 1,25D-binding protein associated with plasma membrane caveolae.
Similar articles
- A specific binding protein/receptor for 1alpha,25-dihydroxyvitamin D(3) is present in an intestinal caveolae membrane fraction.
Norman AW, Olivera CJ, Barreto Silva FR, Bishop JE. Norman AW, et al. Biochem Biophys Res Commun. 2002 Nov 1;298(3):414-9. doi: 10.1016/s0006-291x(02)02482-8. Biochem Biophys Res Commun. 2002. PMID: 12413957 - Caveolae and caveolin-1 are implicated in 1alpha,25(OH)2-vitamin D3-dependent modulation of Src, MAPK cascades and VDR localization in skeletal muscle cells.
Buitrago C, Boland R. Buitrago C, et al. J Steroid Biochem Mol Biol. 2010 Jul;121(1-2):169-75. doi: 10.1016/j.jsbmb.2010.03.002. Epub 2010 Mar 6. J Steroid Biochem Mol Biol. 2010. PMID: 20211253 - 1α,25 dihydroxi-vitamin D₃ modulates CDK4 and CDK6 expression and localization.
Irazoqui AP, Heim NB, Boland RL, Buitrago CG. Irazoqui AP, et al. Biochem Biophys Res Commun. 2015 Mar 27;459(1):137-42. doi: 10.1016/j.bbrc.2015.02.083. Epub 2015 Feb 23. Biochem Biophys Res Commun. 2015. PMID: 25721671 - Minireview: vitamin D receptor: new assignments for an already busy receptor.
Norman AW. Norman AW. Endocrinology. 2006 Dec;147(12):5542-8. doi: 10.1210/en.2006-0946. Epub 2006 Aug 31. Endocrinology. 2006. PMID: 16946007 Review. - The vitamin D hormone and its nuclear receptor: molecular actions and disease states.
Haussler MR, Haussler CA, Jurutka PW, Thompson PD, Hsieh JC, Remus LS, Selznick SH, Whitfield GK. Haussler MR, et al. J Endocrinol. 1997 Sep;154 Suppl:S57-73. J Endocrinol. 1997. PMID: 9379138 Review.
Cited by
- Chaperone properties of pdia3 participate in rapid membrane actions of 1α,25-dihydroxyvitamin d3.
Chen J, Lobachev KS, Grindel BJ, Farach-Carson MC, Hyzy SL, El-Baradie KB, Olivares-Navarrete R, Doroudi M, Boyan BD, Schwartz Z. Chen J, et al. Mol Endocrinol. 2013 Jul;27(7):1065-77. doi: 10.1210/me.2012-1277. Epub 2013 May 9. Mol Endocrinol. 2013. PMID: 23660595 Free PMC article. - 1alpha,25-Dihydroxyvitamin D(3) antiproliferative actions involve vitamin D receptor-mediated activation of MAPK pathways and AP-1/p21(waf1) upregulation in human osteosarcoma.
Wu W, Zhang X, Zanello LP. Wu W, et al. Cancer Lett. 2007 Aug 28;254(1):75-86. doi: 10.1016/j.canlet.2007.02.013. Epub 2007 Apr 6. Cancer Lett. 2007. PMID: 17412493 Free PMC article. - The yin and yang of vitamin D receptor (VDR) signaling in neoplastic progression: operational networks and tissue-specific growth control.
Campbell FC, Xu H, El-Tanani M, Crowe P, Bingham V. Campbell FC, et al. Biochem Pharmacol. 2010 Jan 1;79(1):1-9. doi: 10.1016/j.bcp.2009.09.005. Epub 2009 Sep 6. Biochem Pharmacol. 2010. PMID: 19737544 Free PMC article. Review. - Vitamin D metabolism, mechanism of action, and clinical applications.
Bikle DD. Bikle DD. Chem Biol. 2014 Mar 20;21(3):319-29. doi: 10.1016/j.chembiol.2013.12.016. Epub 2014 Feb 13. Chem Biol. 2014. PMID: 24529992 Free PMC article. Review. - Vitamin D and vitamin D receptor in patients with ophthalmic pterygium.
Maxia C, Murtas D, Corrias M, Zucca I, Minerba L, Piras F, Marinelli C, Perra MT. Maxia C, et al. Eur J Histochem. 2017 Oct 30;61(4):2837. doi: 10.4081/ejh.2017.2837. Eur J Histochem. 2017. PMID: 29313597 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials